122 related articles for article (PubMed ID: 1526680)
1. Changes in lymphocyte subpopulations in patients treated with cefodizime for acute lower respiratory tract infections.
Valcke Y; Van der Straeten M
Infection; 1992; 20 Suppl 1():S58-60. PubMed ID: 1526680
[TBL] [Abstract][Full Text] [Related]
2. Immunological effects of cefodizime in patients undergoing antineoplastic chemotherapy.
Mallmann P; Brühl P
Infection; 1992; 20 Suppl 1():S67-70. PubMed ID: 1526683
[TBL] [Abstract][Full Text] [Related]
3. Review of effectiveness of cefodizime in the treatment of lower respiratory tract infections with parenchymal involvement.
Pauwels RA
Infection; 1992; 20 Suppl 1():S26-30. PubMed ID: 1526672
[TBL] [Abstract][Full Text] [Related]
4. Cefodizime stimulates subpopulations of cells mediating spontaneous or antibody-dependent cytotoxicity in patients with bacterial infections.
Auer IO; Hardörfer C; Zimmermann I
Infection; 1992; 20 Suppl 1():S54-7. PubMed ID: 1526679
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation and immunomodulatory study of cefodizime].
Li G; Zhang Y; Ji M
Zhonghua Nei Ke Za Zhi; 1997 Nov; 36(11):759-63. PubMed ID: 10451950
[TBL] [Abstract][Full Text] [Related]
6. Cefodizime once daily in the treatment of lower respiratory tract infections.
Piovano CF; Palombini BC; Dagrosa EE; Mendoza F; Facco EB
Arzneimittelforschung; 1997 May; 47(5):674-7. PubMed ID: 9205786
[TBL] [Abstract][Full Text] [Related]
7. In-vitro activity of cefodizime against respiratory pathogens.
Wise R; Andrews JM; Ashby JP
J Antimicrob Chemother; 1990 Nov; 26 Suppl C():9-12. PubMed ID: 2127417
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and pharmacokinetic evaluation of cefodizime in children].
Hirabayashi Y; Higashino H; Kino M; Nobori U; Okazaki H; Kitamura N; Kobayashi Y
Jpn J Antibiot; 1989 Jun; 42(6):1366-80. PubMed ID: 2795860
[TBL] [Abstract][Full Text] [Related]
9. Immunopharmacological activity of cefodizime in young and elderly subjects: in vitro and ex vivo studies.
Meroni PL; Capsoni F; Borghi MO; Barcellini W; Minonzio F; Ongari AM; Fain C; Hu C; Brambilla G; Pettenati C
Infection; 1992; 20 Suppl 1():S61-3. PubMed ID: 1526681
[TBL] [Abstract][Full Text] [Related]
10. [Bacteriological and clinical studies of cefodizime in pediatrics].
Akita H; Sato Y; Iwata S; Sunakawa K
Jpn J Antibiot; 1991 Apr; 44(4):398-411. PubMed ID: 1880919
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of cefixime in pediatric respiratory tract infections].
Iwai N; Nakamura H; Kasai K; Ozaki T; Matsui Y; Tauchi N; Yamaguchi H; Taneda Y; Maki T
Jpn J Antibiot; 1991 Jan; 44(1):35-47. PubMed ID: 2041146
[TBL] [Abstract][Full Text] [Related]
12. Cefodizime given in single or divided doses for the treatment of lower respiratory tract infection.
Palombini BC; André-Alves MR; Dagrosa EE
Arzneimittelforschung; 1997 Mar; 47(3):299-302. PubMed ID: 9105549
[TBL] [Abstract][Full Text] [Related]
13. [Ceftriaxone in the therapy of infections of the lower respiratory tract: comparison with cefotaxime].
Lanni N; Scaglione B
Minerva Med; 1986 Mar; 77(9-10):317-9. PubMed ID: 3485265
[TBL] [Abstract][Full Text] [Related]
14. Cefodizime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Barradell LB; Brogden RN
Drugs; 1992 Nov; 44(5):800-34. PubMed ID: 1280568
[TBL] [Abstract][Full Text] [Related]
15. Comparative, multicenter studies of cefixime and amoxicillin in the treatment of respiratory tract infections.
Kiani R; Johnson D; Nelson B
Am J Med; 1988 Sep; 85(3A):6-13. PubMed ID: 3048092
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections.
Neu HC; Chick TW
Chest; 1993 Nov; 104(5):1393-9. PubMed ID: 8222794
[TBL] [Abstract][Full Text] [Related]
17. [Experimental and clinical studies on cefodizime in pediatrics].
Nakamura H; Miyazu M; Kasai K; Iwai N; Taneda Y
Jpn J Antibiot; 1989 Jun; 42(6):1322-35. PubMed ID: 2795856
[TBL] [Abstract][Full Text] [Related]
18. [Clinical experience with cefodizime in pediatric field].
Sekiguchi T; Okamoto T; Ohara K; Kouzan H; Nishimori M; Miyazaki M
Jpn J Antibiot; 1989 Jun; 42(6):1391-8. PubMed ID: 2795863
[TBL] [Abstract][Full Text] [Related]
19. [Effect of cefodizime on cellular immunity in patients with lung cancer].
Ma Z; Chen P; Hou X
Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):190-2. PubMed ID: 11776832
[TBL] [Abstract][Full Text] [Related]
20. Influence of cefodizime on the reagibility of human leukocytes.
Limbert M; Müllner H; Shah PM
Infection; 1992; 20 Suppl 1():S48-50. PubMed ID: 1388140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
